ISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT)Jae Duck Choi, Seong Il Seo|Scientific Reports|2021Cited by 22
ISL1 Romotes Enzalutamide Resistance in Castration-resistant Prostate Cancer (CRPC) through Epithelial to Mesenchymal Transition (EMT)Jae Duck Choi, Seong Il Seo|Research Square|2021Cited by 0